Private Trust Co. NA Has $213,000 Holdings in ICU Medical, Inc. (NASDAQ:ICUI)

Private Trust Co. NA trimmed its position in shares of ICU Medical, Inc. (NASDAQ:ICUI) by 21.3% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,168 shares of the medical instruments supplier’s stock after selling 317 shares during the quarter. Private Trust Co. NA’s holdings in ICU Medical were worth $213,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also made changes to their positions in ICUI. Dimensional Fund Advisors LP lifted its stake in ICU Medical by 21.7% in the second quarter. Dimensional Fund Advisors LP now owns 311,542 shares of the medical instruments supplier’s stock valued at $36,996,000 after acquiring an additional 55,588 shares during the last quarter. Charles Schwab Investment Management Inc. boosted its holdings in ICU Medical by 10.2% in the third quarter. Charles Schwab Investment Management Inc. now owns 301,107 shares of the medical instruments supplier’s stock worth $54,868,000 after purchasing an additional 27,927 shares in the last quarter. WCM Investment Management LLC increased its position in ICU Medical by 1.3% during the third quarter. WCM Investment Management LLC now owns 259,481 shares of the medical instruments supplier’s stock worth $45,272,000 after buying an additional 3,407 shares during the last quarter. Bank of New York Mellon Corp raised its holdings in ICU Medical by 11.5% during the second quarter. Bank of New York Mellon Corp now owns 216,509 shares of the medical instruments supplier’s stock valued at $25,710,000 after buying an additional 22,310 shares in the last quarter. Finally, Federated Hermes Inc. lifted its position in shares of ICU Medical by 9.3% in the second quarter. Federated Hermes Inc. now owns 215,808 shares of the medical instruments supplier’s stock worth $25,627,000 after buying an additional 18,301 shares during the last quarter. Institutional investors own 96.10% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on ICUI shares. Needham & Company LLC reissued a “hold” rating on shares of ICU Medical in a report on Wednesday, November 13th. KeyCorp increased their price target on ICU Medical from $198.00 to $209.00 and gave the company an “overweight” rating in a report on Wednesday, November 13th. Raymond James boosted their price objective on shares of ICU Medical from $158.00 to $190.00 and gave the stock an “outperform” rating in a research note on Thursday, September 12th. StockNews.com upgraded shares of ICU Medical from a “hold” rating to a “buy” rating in a research note on Wednesday, November 20th. Finally, Jefferies Financial Group started coverage on shares of ICU Medical in a report on Monday, October 14th. They set a “hold” rating and a $183.00 price target for the company. Two analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $173.00.

Insiders Place Their Bets

In other ICU Medical news, CEO Vivek Jain sold 12,000 shares of the firm’s stock in a transaction that occurred on Tuesday, October 1st. The stock was sold at an average price of $178.46, for a total value of $2,141,520.00. Following the completion of the sale, the chief executive officer now owns 104,593 shares in the company, valued at approximately $18,665,666.78. This trade represents a 10.29 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Christian B. Voigtlander sold 1,962 shares of ICU Medical stock in a transaction that occurred on Monday, November 25th. The stock was sold at an average price of $169.08, for a total value of $331,734.96. The disclosure for this sale can be found here. Insiders have sold 40,364 shares of company stock worth $6,876,478 in the last ninety days. Insiders own 6.70% of the company’s stock.

ICU Medical Trading Up 1.3 %

Shares of ICUI stock opened at $159.75 on Friday. The firm has a market capitalization of $3.91 billion, a P/E ratio of -34.96 and a beta of 0.66. ICU Medical, Inc. has a 1 year low of $83.26 and a 1 year high of $196.26. The firm’s fifty day simple moving average is $175.28 and its 200 day simple moving average is $146.60. The company has a current ratio of 2.29, a quick ratio of 1.03 and a debt-to-equity ratio of 0.75.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.